These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16625143)

  • 21. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
    Furfaro N
    Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
    [No Abstract]   [Full Text] [Related]  

  • 22. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
    Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
    Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab treatment of refractory rheumatoid arthritis.
    Summers KM; Kockler DR
    Ann Pharmacother; 2005 Dec; 39(12):2091-5. PubMed ID: 16249269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of rheumatoid arthritis with adalimumab. Results from a Cochrane review].
    Pedersen SJ; Hetland ML; Østergaard M
    Ugeskr Laeger; 2006 Aug; 168(35):2899-903. PubMed ID: 16982019
    [No Abstract]   [Full Text] [Related]  

  • 25. Long term treatment of rheumatoid arthritis with rituximab.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
    Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tocilizumab for rheumatoid arthritis.
    Drug Ther Bull; 2010 Jan; 48(1):9-12. PubMed ID: 20040568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
    Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L
    Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773
    [No Abstract]   [Full Text] [Related]  

  • 28. Rituximab for rheumatoid arthritis.
    Okamoto H; Kamatani N
    N Engl J Med; 2004 Oct; 351(18):1909; author reply 1909. PubMed ID: 15509828
    [No Abstract]   [Full Text] [Related]  

  • 29. Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis.
    Wong JB; Singh G; Kavanaugh A
    Am J Med; 2002 Oct; 113(5):400-8. PubMed ID: 12401535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective.
    Mittendorf T; Dietz B; Sterz R; Cifaldi MA; Kupper H; von der Schulenburg JM
    Rheumatology (Oxford); 2008 Feb; 47(2):188-93. PubMed ID: 18174232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.
    Strand V; Balbir-Gurman A; Pavelka K; Emery P; Li N; Yin M; Lehane PB; Agarwal S
    Rheumatology (Oxford); 2006 Dec; 45(12):1505-13. PubMed ID: 17062648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous methotrexate to cut costs?
    Hassanzadeh R; Mangan C; France J; Bawa S
    J Rheumatol; 2012 Aug; 39(8):1764-5. PubMed ID: 22859538
    [No Abstract]   [Full Text] [Related]  

  • 33. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
    Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
    [No Abstract]   [Full Text] [Related]  

  • 34. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    van Vollenhoven RF
    Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
    [No Abstract]   [Full Text] [Related]  

  • 35. Discussion. Treatment algorithm: managing rheumatoid arthritis.
    Calabrese DC; Konop R; Cannon E; Maves TK; Casberg JJ; Meske L; Coleman IC; Orland BI; Florentine MJ; Southwell Y; Harris MR; Yoder DM
    Manag Care; 2001 Jul; 10(7 Suppl):19-24. PubMed ID: 11729430
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer drug approved for RA.
    Health News; 2006 Apr; 12(4):2. PubMed ID: 16572516
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 38. Etanercept or infliximab: the patient's considerations.
    Sherrick RC
    Arch Intern Med; 2006 Jul; 166(13):1418; author reply 1418. PubMed ID: 16832010
    [No Abstract]   [Full Text] [Related]  

  • 39. Rituximab in lupus and beyond: the state of the art.
    Hughes G
    Lupus; 2009 Jun; 18(7):639-44. PubMed ID: 19433465
    [No Abstract]   [Full Text] [Related]  

  • 40. Rheumatoid arthritis treatment progressing.
    Health News; 2004 Aug; 10(8):9. PubMed ID: 15551458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.